Evaluation of the immunoprotective effects of eight recombinant proteins from Baylisascaris schroederi in mice model

Abstract Background Baylisascaris schroederi is the most common and harmful intestinal parasitic nematode of giant pandas, causing ascariasis. Although drug deworming is the main measure to control ascariasis in captive giant pandas, prolonged and repeated use of deworming drugs might induce resista...

Full description

Bibliographic Details
Main Authors: Lang Xiong, Ling Chen, Yanxin Chen, Nengxing Shen, Ruiqi Hua, Guangyou Yang
Format: Article
Language:English
Published: BMC 2023-07-01
Series:Parasites & Vectors
Subjects:
Online Access:https://doi.org/10.1186/s13071-023-05886-y
_version_ 1797769666803793920
author Lang Xiong
Ling Chen
Yanxin Chen
Nengxing Shen
Ruiqi Hua
Guangyou Yang
author_facet Lang Xiong
Ling Chen
Yanxin Chen
Nengxing Shen
Ruiqi Hua
Guangyou Yang
author_sort Lang Xiong
collection DOAJ
description Abstract Background Baylisascaris schroederi is the most common and harmful intestinal parasitic nematode of giant pandas, causing ascariasis. Although drug deworming is the main measure to control ascariasis in captive giant pandas, prolonged and repeated use of deworming drugs might induce resistance in nematodes and drug residues in giant pandas. Therefore, developing a safe and effective vaccine might provide a novel strategy to prevent ascariasis in captive giant pandas. Methods Four highly expressed secretome genes encoding excretory and secretory proteins of B. schroederi, including transthyretin-like protein 46 (BsTLP), uncharacterized protein (BsUP), hypothetical protein 1 (BsHP1), and hypothetical protein 2 (BsHP2) and four functional genes [(encoding Galectin (BsGAL), glutathione S-transferase (BsGST), fatty acid-binding protein (BsFABP), and thioredoxin peroxidase (BsTPX)] were identified based on genome and transcriptome databases of B. schroederi and used to construct recombinant proteins via prokaryotic expression. Kunming mice were vaccinated subcutaneously twice with the recombinant proteins (50 μg/mouse) mixed with Quil A adjuvant with a 2-week interval and then orally challenged with 3000 infective eggs. The immunoprotective effects of the eight recombinant proteins on mice were assessed comprehensively using surface lesion histology scores of the mouse liver and lung, larval worm reduction, serum antibody levels (IgG, IgE, IgA, IgG1, and IgG2a), and cytokine production [interferon gamma (IFN-γ), interleukin (IL)-2, IL-4, IL-5, and IL-10]. Results Mice vaccinated with recombinant (r)BsUP (76.5%), rBsGAL (74.7%), and rBsHP2 (71.5%) showed a significant (P < 0.001) reduction in the larval worm rate compared with that in the adjuvant control. Besides, the surface lesions in the liver and lung of the vaccinated mice were alleviated. Serum levels of total IgG, IgE, IgA, IgG1, IgG2a, and cytokines, including IL-10, IL-5, and IFN-γ, were significantly higher (P < 0.001) than those in the control group. Conclusions The results showed that candidate three vaccines (rBsUP, rBsGAL, and rBsHP2) could provide effective protection against egg infection in mice associated with a mixed Th1/2-type immune response. Graphical Abstract
first_indexed 2024-03-12T21:11:20Z
format Article
id doaj.art-c68ff4bd081543608d4aa6c439bd2036
institution Directory Open Access Journal
issn 1756-3305
language English
last_indexed 2024-03-12T21:11:20Z
publishDate 2023-07-01
publisher BMC
record_format Article
series Parasites & Vectors
spelling doaj.art-c68ff4bd081543608d4aa6c439bd20362023-07-30T11:09:04ZengBMCParasites & Vectors1756-33052023-07-0116111310.1186/s13071-023-05886-yEvaluation of the immunoprotective effects of eight recombinant proteins from Baylisascaris schroederi in mice modelLang Xiong0Ling Chen1Yanxin Chen2Nengxing Shen3Ruiqi Hua4Guangyou Yang5Department of Parasitology, College of Veterinary Medicine, Sichuan Agricultural UniversityDepartment of Parasitology, College of Veterinary Medicine, Sichuan Agricultural UniversityDepartment of Parasitology, College of Veterinary Medicine, Sichuan Agricultural UniversityDepartment of Parasitology, College of Veterinary Medicine, Sichuan Agricultural UniversityDepartment of Parasitology, College of Veterinary Medicine, Sichuan Agricultural UniversityDepartment of Parasitology, College of Veterinary Medicine, Sichuan Agricultural UniversityAbstract Background Baylisascaris schroederi is the most common and harmful intestinal parasitic nematode of giant pandas, causing ascariasis. Although drug deworming is the main measure to control ascariasis in captive giant pandas, prolonged and repeated use of deworming drugs might induce resistance in nematodes and drug residues in giant pandas. Therefore, developing a safe and effective vaccine might provide a novel strategy to prevent ascariasis in captive giant pandas. Methods Four highly expressed secretome genes encoding excretory and secretory proteins of B. schroederi, including transthyretin-like protein 46 (BsTLP), uncharacterized protein (BsUP), hypothetical protein 1 (BsHP1), and hypothetical protein 2 (BsHP2) and four functional genes [(encoding Galectin (BsGAL), glutathione S-transferase (BsGST), fatty acid-binding protein (BsFABP), and thioredoxin peroxidase (BsTPX)] were identified based on genome and transcriptome databases of B. schroederi and used to construct recombinant proteins via prokaryotic expression. Kunming mice were vaccinated subcutaneously twice with the recombinant proteins (50 μg/mouse) mixed with Quil A adjuvant with a 2-week interval and then orally challenged with 3000 infective eggs. The immunoprotective effects of the eight recombinant proteins on mice were assessed comprehensively using surface lesion histology scores of the mouse liver and lung, larval worm reduction, serum antibody levels (IgG, IgE, IgA, IgG1, and IgG2a), and cytokine production [interferon gamma (IFN-γ), interleukin (IL)-2, IL-4, IL-5, and IL-10]. Results Mice vaccinated with recombinant (r)BsUP (76.5%), rBsGAL (74.7%), and rBsHP2 (71.5%) showed a significant (P < 0.001) reduction in the larval worm rate compared with that in the adjuvant control. Besides, the surface lesions in the liver and lung of the vaccinated mice were alleviated. Serum levels of total IgG, IgE, IgA, IgG1, IgG2a, and cytokines, including IL-10, IL-5, and IFN-γ, were significantly higher (P < 0.001) than those in the control group. Conclusions The results showed that candidate three vaccines (rBsUP, rBsGAL, and rBsHP2) could provide effective protection against egg infection in mice associated with a mixed Th1/2-type immune response. Graphical Abstracthttps://doi.org/10.1186/s13071-023-05886-yRecombinant proteinsBaylisascaris schroederiGiant pandaImmunoprotective effectMouse model
spellingShingle Lang Xiong
Ling Chen
Yanxin Chen
Nengxing Shen
Ruiqi Hua
Guangyou Yang
Evaluation of the immunoprotective effects of eight recombinant proteins from Baylisascaris schroederi in mice model
Parasites & Vectors
Recombinant proteins
Baylisascaris schroederi
Giant panda
Immunoprotective effect
Mouse model
title Evaluation of the immunoprotective effects of eight recombinant proteins from Baylisascaris schroederi in mice model
title_full Evaluation of the immunoprotective effects of eight recombinant proteins from Baylisascaris schroederi in mice model
title_fullStr Evaluation of the immunoprotective effects of eight recombinant proteins from Baylisascaris schroederi in mice model
title_full_unstemmed Evaluation of the immunoprotective effects of eight recombinant proteins from Baylisascaris schroederi in mice model
title_short Evaluation of the immunoprotective effects of eight recombinant proteins from Baylisascaris schroederi in mice model
title_sort evaluation of the immunoprotective effects of eight recombinant proteins from baylisascaris schroederi in mice model
topic Recombinant proteins
Baylisascaris schroederi
Giant panda
Immunoprotective effect
Mouse model
url https://doi.org/10.1186/s13071-023-05886-y
work_keys_str_mv AT langxiong evaluationoftheimmunoprotectiveeffectsofeightrecombinantproteinsfrombaylisascarisschroederiinmicemodel
AT lingchen evaluationoftheimmunoprotectiveeffectsofeightrecombinantproteinsfrombaylisascarisschroederiinmicemodel
AT yanxinchen evaluationoftheimmunoprotectiveeffectsofeightrecombinantproteinsfrombaylisascarisschroederiinmicemodel
AT nengxingshen evaluationoftheimmunoprotectiveeffectsofeightrecombinantproteinsfrombaylisascarisschroederiinmicemodel
AT ruiqihua evaluationoftheimmunoprotectiveeffectsofeightrecombinantproteinsfrombaylisascarisschroederiinmicemodel
AT guangyouyang evaluationoftheimmunoprotectiveeffectsofeightrecombinantproteinsfrombaylisascarisschroederiinmicemodel